Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Healing minds: breathing and biofeedback show promise for ADHD in children

NCT ID NCT06648252

Symptom relief Sponsor: Hoskinson Health and Wellness Clinic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a 10-week program of biofeedback and breathing exercises in children and teens aged 6-18 with ADHD. The goal was to see if these techniques could reduce ADHD symptoms and improve heart rate variability. The small, completed trial involved 12 participants and used a waiting-list control group.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
biofeedback and breathing practices
What this could lead to
If it works, this could offer a non-drug way to help children and teens manage ADHD symptoms like inattention and hyperactivity.
What could go wrong
This is a very small, early study with only 12 participants. Results may not apply to everyone, and the placebo effect could play a role.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Jul 2024

Finished

Jan 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 6-18 years * Male and female children and adolescents * Confirmed diagnosis of ADHD using the DSM-5-TR criteria Exclusion Criteria: * Severe, uncontrolled mental illness including depression, panic disorders * Suicidal ideology * Psychosis * Severe, uncontrolled, autonomic nervous system or metabolic disorders including hypertension, diabetes, hypotension, autoimmune disease, or any condition that would limit their participation in the intervention * Disorders involving severe impairments of memory or neurological conditions such as seizures * Pregnant or nursing females may not participate because of some of the tests that are required for the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention deficit hyperactivity disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Attention deficit hyperactivity disorder

Contacts and locations

Locations

  • Hoskinson Health and Wellness Clinic

    Gillette, Wyoming, 82718, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.